AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Príomhchruthaitheoirí: | , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2023-10-01
|
Sraith: | IBRO Neuroscience Reports |
Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |